Cargando…
Protective neutralizing epitopes in SARS‐CoV‐2
The COVID‐19 pandemic has caused an unprecedented health crisis and economic burden worldwide. Its etiological agent SARS‐CoV‐2, a new virus in the coronavirus family, has infected hundreds of millions of people worldwide. SARS‐CoV‐2 has evolved over the past 2 years to increase its transmissibility...
Autores principales: | Liu, Hejun, Wilson, Ian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348472/ https://www.ncbi.nlm.nih.gov/pubmed/35599305 http://dx.doi.org/10.1111/imr.13084 |
Ejemplares similares
-
Effect of farnesyltransferase inhibitors on SARS-CoV-2
por: Weber, Lea, et al.
Publicado: (2023) -
Clinical evaluation of SARS-CoV-2 point-of-care antibody tests
por: Robosa, Roselle S., et al.
Publicado: (2020) -
SARS-CoV-2 positivity in rectal swabs: implication for possible transmission
por: Novazzi, Federica, et al.
Publicado: (2020) -
Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2020) -
Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings
por: Chong, Brian S.W., et al.
Publicado: (2020)